Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jorge Saucedo to Platelet Aggregation Inhibitors

This is a "connection" page, showing publications Jorge Saucedo has written about Platelet Aggregation Inhibitors.

 
Connection Strength
  
 
 
3.675
  
  1. Saucedo JF, Angiolillo DJ, DeRaad R, Frelinger AL, Gurbel PA, Costigan TM, Jakubowski JA, Ojeh CK, Duvvuru S, Effron MB. Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study. Thromb Haemost. 2013 Feb; 109(2):347-55.
    View in: PubMed
    Score: 0.346
  2. Hanna EB, Rao SV, Manoukian SV, Saucedo JF. The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes. JACC Cardiovasc Interv. 2010 Dec; 3(12):1209-19.
    View in: PubMed
    Score: 0.301
  3. Saucedo JF. Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention. J Thromb Thrombolysis. 2010 Aug; 30(2):200-9.
    View in: PubMed
    Score: 0.294
  4. Hanna EB, Glancy DL, Saucedo JF. Antiplatelet and anticoagulant therapies in acute coronary syndromes. Cardiovasc Drugs Ther. 2010 Feb; 24(1):61-70.
    View in: PubMed
    Score: 0.284
  5. Saucedo JF. Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update? Am J Cardiol. 2009 Sep 07; 104(5 Suppl):4C-8C.
    View in: PubMed
    Score: 0.277
  6. Jennings LK, Saucedo JF. Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes. Curr Opin Cardiol. 2008 Jul; 23(4):302-8.
    View in: PubMed
    Score: 0.255
  7. Saucedo JF, Lui HK, Garza L, Guerra GJ, Jacoski MV, Jennings LK. Comparative pharmacodynamic evaluation of eptifibatide and abciximab in patients with non-ST-segment elevation acute coronary syndromes: the TAM2 study. J Thromb Thrombolysis. 2004 Oct; 18(2):67-74.
    View in: PubMed
    Score: 0.196
  8. Saucedo JF, Garza L, Wolford DC, Cook SL, Ramanathan KB, Matin Z, McGrew FA, Jacoski MV, Jennings LK. Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study). Am J Cardiol. 2004 May 15; 93(10):1279-82.
    View in: PubMed
    Score: 0.191
  9. Grodecki K, Huczek Z, Scislo P, Kowara M, Raposeiras-Roub?n S, D'Ascenzo F, Abu-Assi E, Henriques JPS, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Song XT, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Nie SP, Fujii T, Correia L, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Giordana F, Scarano S, Gaita F, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Opolski G, Filipiak KJ. Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study. Thromb Res. 2018 08; 168:156-163.
    View in: PubMed
    Score: 0.127
  10. Garay A, Ariza-Sol? A, Formiga F, Raposeiras-Roub?n S, Abu-Assi E, S?nchez-Salado JC, Lorente V, Alegre O, Henriques JPS, D'Ascenzo F, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Giordana F, Gaita F, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Cequier A. Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry. Thromb Haemost. 2018 05; 118(5):929-938.
    View in: PubMed
    Score: 0.125
  11. D'Ascenzo F, Abu-Assi E, Raposeiras-Roub?n S, Simao Henriques JP, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia LC, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Giordana F, Scarano S, Gaita F, Kowara M, Filipiak KJ, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S. BleeMACS: rationale and design of the study. J Cardiovasc Med (Hagerstown). 2016 Oct; 17(10):744-9.
    View in: PubMed
    Score: 0.113
  12. Giordana F, Montefusco A, D'Ascenzo F, Moretti C, Scarano S, Abu-Assi E, Raposeiras-Roub?n S, Henriques JP, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Gaita F. Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe. Int J Cardiol. 2016 Oct 01; 220:488-95.
    View in: PubMed
    Score: 0.111
  13. Diodati JG, Saucedo JF, Cardillo TE, Jakubowski JA, Henneges C, Effron MB, Lipkin FR, Walker JR, Duvvuru S, Sundseth SS, Fisher HN, Angiolillo DJ. Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial. Thromb Haemost. 2014 Aug; 112(2):311-22.
    View in: PubMed
    Score: 0.095
  14. Dasari TW, Cohen DJ, Kleiman NS, Keyes MJ, Yen CH, Hanna EB, Saucedo JF. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry). Am J Cardiol. 2014 Feb 15; 113(4):621-5.
    View in: PubMed
    Score: 0.093
  15. Diercks DB, Kontos MC, Hollander JE, Mumma BE, Holmes DN, Wiviott S, Saucedo JF, de Lemos JA. ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR. Am J Emerg Med. 2013 Jul; 31(7):1005-11.
    View in: PubMed
    Score: 0.089
  16. Angiolillo DJ, Welsh RC, Trenk D, Neumann FJ, Conley PB, McClure MW, Stephens G, Kochman J, Jennings LK, Gurbel PA, W?jcik J, Dabrowski M, Saucedo JF, Stumpf J, Buerke M, Broderick S, Harrington RA, Rao SV. Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial. Circ Cardiovasc Interv. 2012 Jun; 5(3):347-56.
    View in: PubMed
    Score: 0.083
  17. Roe MT, White JA, Kaul P, Tricoci P, Lokhnygina Y, Miller CD, van't Hof AW, Montalescot G, James SK, Saucedo J, Ohman EM, Pollack CV, Hochman JS, Armstrong PW, Giugliano RP, Harrington RA, Van de Werf F, Califf RM, Newby LK. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial. Circ Cardiovasc Qual Outcomes. 2012 Mar 01; 5(2):205-13.
    View in: PubMed
    Score: 0.082
  18. Angiolillo DJ, Badimon JJ, Saucedo JF, Frelinger AL, Michelson AD, Jakubowski JA, Zhu B, Ojeh CK, Baker BA, Effron MB. A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. Eur Heart J. 2011 Apr; 32(7):838-46.
    View in: PubMed
    Score: 0.076
  19. Angiolillo DJ, Saucedo JF, Deraad R, Frelinger AL, Gurbel PA, Costigan TM, Jakubowski JA, Ojeh CK, Effron MB. Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study. J Am Coll Cardiol. 2010 Sep 21; 56(13):1017-23.
    View in: PubMed
    Score: 0.074
  20. Gurbel PA, Bliden KP, Saucedo JF, Suarez TA, DiChiara J, Antonino MJ, Mahla E, Singla A, Herzog WR, Bassi AK, Hennebry TA, Gesheff TB, Tantry US. Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study. J Am Coll Cardiol. 2009 Feb 24; 53(8):648-57.
    View in: PubMed
    Score: 0.067
  21. Cohen M, Hoekstra J, Giugliano R, Granger CB, Gurbel PA, Hollander JE, Manoukian SV, Pollack CV, Saucedo JF. Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion. J Interv Cardiol. 2008 Aug; 21(4):283-99.
    View in: PubMed
    Score: 0.064
  22. Saucedo JF, Aude W, Pacheco R, Thorn B, Matin Z, Husain K, Garza L. Inhibition of platelet aggregation with eptifibatide, bivalirudin, and heparin in patients undergoing percutaneous coronary intervention receiving clopidogrel pretreatment (The PharmacoDynamic Evaluation of Angiomax, Clopidogrel with or without INtegrilin [DEACON] study). Am J Cardiol. 2005 Jun 15; 95(12):1453-6.
    View in: PubMed
    Score: 0.052
  23. Fahdi IE, Saucedo JF, Hennebry T, Ghani M, Sadanandan S, Garza-Arreola L. Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2004 Feb 15; 93(4):453-5.
    View in: PubMed
    Score: 0.047
  24. Labinaz M, Madan M, O'Shea JO, Kilaru R, Chin W, Pieper K, McGuire DK, Saucedo JF, Talley JD, Lui H, Kitt MM, Califf RM, Tcheng JT. Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial). Am J Cardiol. 2002 Sep 15; 90(6):585-90.
    View in: PubMed
    Score: 0.043
  25. Steinhubl SR, Talley JD, Braden GA, Tcheng JE, Casterella PJ, Moliterno DJ, Navetta FI, Berger PB, Popma JJ, Dangas G, Gallo R, Sane DC, Saucedo JF, Jia G, Lincoff AM, Theroux P, Holmes DR, Teirstein PS, Kereiakes DJ. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation. 2001 May 29; 103(21):2572-8.
    View in: PubMed
    Score: 0.039
  26. Zhang D, Song X, Chen Y, Raposeiras-Roub?n S, Abu-Assi E, Henriques JPS, D'Ascenzo F, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie S, Fujii T, Correia L, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Garay A, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Giordana F, Kowara M, Filipiak K, Wang X, Yan Y, Fan J, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S. Antithrombotic Therapy in Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary Syndromes. Angiology. 2020 07; 71(6):576-577.
    View in: PubMed
    Score: 0.036
  27. Zhang D, Song X, Chen Y, Raposeiras-Roub?n S, Abu-Assi E, Henriques JPS, D'Ascenzo F, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie S, Fujii T, Correia L, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Garay A, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Giordana F, Kowara M, Filipiak K, Wang X, Yan Y, Fan J, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S. Outcome of Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary Syndromes. Angiology. 2020 Apr; 71(4):324-332.
    View in: PubMed
    Score: 0.035
  28. Hess CN, Peterson ED, Peng SA, de Lemos JA, Fosbol EL, Thomas L, Bhatt DL, Saucedo JF, Wang TY. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation. J Am Coll Cardiol. 2015 Aug 11; 66(6):616-27.
    View in: PubMed
    Score: 0.026
  29. Karrowni W, Wang TY, Chen AY, Thomas L, Saucedo JF, El Accaoui RN. Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients. Heart. 2015 Feb; 101(4):264-70.
    View in: PubMed
    Score: 0.025
  30. Yeo KK, Li S, Amsterdam EA, Wang TY, Bhatt DL, Saucedo JF, Kontos MC, Roe MT, French WJ. Comparison of clinical characteristics, treatments and outcomes of patients with ST-elevation acute myocardial infarction with versus without new or presumed new left bundle branch block (from NCDR?). Am J Cardiol. 2012 Feb 15; 109(4):497-501.
    View in: PubMed
    Score: 0.020
  31. Kornowski R, Hong MK, Saucedo J, Satler LF, Pichard AD, Kent KM, Greenberg A, Leon MB. Procedural results and long-term clinical outcomes following coronary stenting in perimyocardial infarction syndromes. Am J Cardiol. 1998 Nov 15; 82(10):1163-7.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.